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ABSTRACT: Monitoring dynamic processes in complex cellular
environments requires the integration of uniformly distributed
detectors within such three-dimensional (3D) networks, to an
extent that the sensor could provide real-time information on
nearby perturbations in a non-invasive manner. In this context, the
development of 3D-printed structures that can function as both
sensors and cell culture platforms emerges as a promising strategy,
not only for mimicking a specific cell niche but also toward
identifying its characteristic physicochemical conditions, such as
concentration gradients. We present herein a 3D cancer model that
incorporates a hydrogel-based scaffold containing gold nanorods.
In addition to sustaining cell growth, the printed nanocomposite
inks display the ability to uncover drug diffusion profiles by
surface-enhanced Raman scattering, with high spatiotemporal resolution. We additionally demonstrate that the acquired information
could pave the way to designing novel strategies for drug discovery in cancer therapy, through correlation of drug diffusion with cell
death.
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■ INTRODUCTION
The extracellular environment and its impact on cell fitness is a
growing area of research, which has initially focused on
mimicking microenvironments by means of tissue-like cell-
culture systems in three dimensions (3D).1−3 However,
monitoring parameters of interest within these structures, such
as spatiotemporal heterogeneity or molecular gradients, is
difficult to achieve experimentally. Hence, not only more
realistic in vitro models are required but also new imaging
technologies should be developed to assess them accurately.4−7
Although 2D cell cultures have allowed the discovery of many
biological processes, these systems lack the cell−cell and cell−
extracellular matrix (ECM) interactions that ultimately generate
specific 3D microenvironments.8,9 Whereas biomolecules can
diffuse freely in the extracellular milieu of 2D cell culturemodels,
gradients of soluble molecules are established along tissues by a
combination of cellular activity and restricted extracellular
diffusion.10,11 Such gradients, along with the 3D internal
structure, strongly influence cell responses and phenotypes in
solid tissues, including tumors.12,13
During the design of in vitro 3D environments, biological
structures can be tailored through the technology used to build
them.14−16 Different approaches can be combined to improve
the outcome and better mimic the features of a native niche.17,18
Recent experiments involving hydrogels and scaffold-based
systems successfully reproduced the 3D physiology of selected
human tissues.19 Even though these approaches have revealed
new elements in cell biology,20 the incorporated third dimension
drastically hampered the efficient capture of dynamic aspects,
such as drug or nutrient transport, by optical methods. The
ability of optical microscopy to map large extracellular
concentration profiles in 3D is limited, especially if other
fluorescent labels are present, which may cause signal overlap,
e.g., in combination with cell-viability dyes.21,22 Other ordinary
sensing techniques involve invasive procedures, which prevent
continuous monitoring of gradually evolving processes. There-
fore, dynamic parameters are not routinely registered in 3D
experiments, thus ignoring their potential effects on cell
behavior. The development of alternative analytical methods
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to rapidly detect gradients in extracellular media is thus required
toward a better understanding of cellular niches and their
implications for the effectiveness of therapeutic methods.
In this context, surface-enhanced Raman scattering (SERS), a
highly sensitive vibrational spectroscopy technique, has emerged
as a tool to evaluate changing environments. By enhancing the
Raman signal of molecules adsorbed onto plasmonic nanostruc-
tures, SERS enables fast, label-free identification of trace analytes
upon laser irradiation.23,24 However, the integration of efficient
Raman signal enhancers inside cellular environments is still in its
infancy, thus hindering the spatiotemporal resolution in SERS
bioimaging.25 We have recently reported the fabrication of
SERS-active scaffolds from inks containing plasmonic gold
nanoparticles,27 as highly efficient platforms for SERS
monitoring in 3D. We hypothesized that a similar system
could be employed to screen biorelevant compounds in 3D
environments while analyzing by SERS the extracellular
gradients created upon drug exposure. We selected methylene
blue (MB) as a drug candidate because it features a high Raman
Figure 1. (a) Scheme of a 3D-printed nanocomposite scaffold comprising gelatin and alginate hydrogels, represented by purple and orange fibers,
respectively. The homogeneous distribution of gold nanorods (AuNRs) within the polymer matrix is represented by yellow bars. (b) SERS intensity of
1 μMmethylene blue (MB) at 450 cm−1 registered by scaffolds (gelatin + 2% alginate) with varying concentrations of AuNRs, from bare scaffolds (no
nanoparticles) to 1000 μM colloidal solution. Error bars show standard deviations from 10 different measurements with three different scaffolds (N =
3, n = 10). (c) SERS intensity of 1 μMMBobtained from scaffolds with 500 μMAuNRs and an increasing alginate percentage up to 2%, (N = 3, n = 10).
(d) SERS intensity (at 450 cm−1) as a function of MB concentration. The yellow bar is a linear fit in the quantitative detection regions, including a
regression line (dotted line) and 95% confidence interval. Each data point corresponds to the signal from 10 spectra collected from three different
scaffolds (N = 3, n = 10). (e) SERS spectra of MB at different concentrations (between 10 nM and 10 μM with 10-fold-increase steps) in cell media,
DMEM10%FBS. (f) SERS intensity ofMB (the red line is a linear fit with 95% confidence interval) in the presence of cell media components (N = 2, n
= 10). An excitation laser line at 785 nm through a 10× objective, with a power of 15.15 mW for 1 s, was used for all measurements. (g) 3D Z-stack
reconstruction of SERS intensity at 450 cm−1 upon MB incubation at 10 μM, recorded with a 785 nm excitation laser through a 20× immersion
objective in confocal mode, with a power of 7 mW and 10 ms of integration time.
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cross-section and has been used as a photosensitizer agent in
antitumor therapy.28−30
We developed a biocompatible gelatin−alginate hydrogel
containing gold nanorods (AuNRs), which could be 3D-printed
to fabricate cell culture scaffolds.31,32 Alginate provides a
strongly anionic character, which facilitates SERS detection of
oppositely charged molecules through electrostatic interactions.
The resulting fast and sensitive response to MB provided a
suitable spatiotemporal resolution. Our results demonstrate
real-time monitoring of drug diffusion in 3D cell cultures,
through the detection of MB gradients within different
environments and upon varying drug administration method-
ologies.
■ RESULTS AND DISCUSSION
3D-printing strategies are particularly efficient at recreating the
tumor niche, due to their ability to control geometric structures
within milli-/microscale resolution. Direct printing of hydrogel
inks is a common approach toward the design of porous,
aqueous environments, which support nutrients and oxygen
transport for cell culture.33,34 Consequently, 3D-printing of
purposely designed hydrogels renders such scaffolds suitable for
cell growth, with a tailored physiological architecture, so that
complex in vitro systems can be acurately reconstructed. Among
various natural polymers, gelatin-alginate mixtures are charac-
terized by outstanding water retention and cell adhesion
facilitated by gelatin-binding domains.35 Since our objective
requires SERS-active inks, we incorporated AuNRs within
selectedmixtures of gelatin−alginate hydrogels (a representative
extinction spectrum of the nanocomposite inks is shown in
Figure S1). Upon printing, the obtained nanocomposite
scaffolds were cross-linked with CaCl2, so divalent cations
(Ca2+) bind anionic blocks in different alginate chains, resulting
in stable 3D networks containing AuNRs, as schematically
depicted in Figure 1a.
We then evaluated the SERS performance of the printed
scaffolds as a function of two key parameters of ink composition:
AuNRs concentration and percentage of alginate. MB was
incubated with the scaffolds at 1 μM concentration. Increasing
AuNR concentrations were found to directly correlate with
higher SERS intensities of the MB vibration at 450 cm−1 (C−
N−C skeletal bending36). The SERS results in Figure 1b
confirm an increase in the number of plasmonic hotspots for
Raman signal amplification so that the MB signal was negligible
for an ink formulation without nanoparticles. On the other hand,
when the percentage of alginate was increased from 0% to 2% at
constant AuNR concentration, the registered SERS intensities
were significantly affected. As illustrated in Figure 1c, scaffolds
containing 2% alginate showed the greatest SERS performance
for MB detection. Although a low MB signal could be measured
from scaffolds lacking alginate, the effect of this polymer
component on signal enhancement was even more intense than
that observed at varying AuNR concentrations. We interpret
these results in terms of electrostatic interactions between
positively charged MB and the anionic alginate-based ink,
facilitating analyte penetration through the scaffold. As a
consequence, MB molecules are more likely to adsorb on
plasmonic nanoparticles, resulting in a higher SERS signal
enhancement.37,38 All scaffolds were thus prepared using inks
containing 2% alginate and 1 mM AuNRs, thereby achieving a
fast, sensitive detection ofMB signal; no extensive preincubation
times with the analyte were needed, in contrast with previous
studies using different analyte−polymer combinations.26,27
SERS spectra collected from varyingMB concentrations showed
that semiquantitative detection could be achieved in the range
from 1 mM down to 0.1 nM (Figure 1d). Within this range, MB
concentration could be approximated by the SERS intensity,
according to the empirical formula log(ISERS) = 0.31 ×
log([MB]) + 4.48, where [MB] is the molar concentration of
MB and ISERS is the SERS intensity (expressed in counts).
Interestingly, the negatively charged hydrogel additionally
hinders the interaction of large proteins with AuNRs,39 which
in combination with the electrostatic attraction effect would
facilitate a reproducible detection of MB in complex cell media
(Dulbecco’s modified Eagle medium, DMEM, with 10% of fetal
bovine serum, FBS). As shown in Figure 1e, the characteristic
peak of MB at 450 cm−1 dominates the SERS spectra, even at
low concentrations and when other biomolecules are present at
orders of magnitude higher concentrations than that of MB. We
propose that our scaffolds can be used for direct, real-time
analysis of biological samples with no need for pretreatment
separation and concentration steps, which are common
requisites for SERS analysis in complex media.40 Although a
decreased sensitivity was observed as compared to aqueous
samples, semiquantitative measurements could be recorded
between 100 μM and 10 nM, thus covering the therapeutic
window range for MB, i.e., drug dosage typically used for
therapy.41 Therefore, changes in MB concentration would
correspond to changes in SERS intensity in a quasi-predictable
manner, which was found to follow a slightly different trend:
log(ISERS) = 0.33 × log([MB]) + 4.39, as illustrated in Figure 1f.
We show in Figure 1g the result of scanning the SERS signal of
10 μMMB (typical concentration for anticancer therapy) in cell
media.29,41 A confocal Raman microscope with a 20× water
immersion objective and scanning steps of 13.3, 10, and 20 μm
in X, Y, and Z, respectively, were employed for precise MB 3D
screening throughout a total volume of (2.0 × 1.5 × 0.3) mm3.
The signal recorded along the XY-plane in Figure S2 shows
constant intensity values, accounting for a homogeneous
distribution of AuNRs at this scale. On the contrary, a SERS
intensity decay was registered at deeper imaging planes, due to
laser spot broadening, decrease of collection efficiency, and
other factors (see also Figure S3). SERS images with higher
spatial resolution could be obtained using a 63× water
immersion objective, allowing us to visualize the local AuNR
distribution along the scaffold (Figure S4). However, this
strategy restricted MB monitoring to much smaller (μm-sized)
areas, since longer measurement times were required to obtain
high spatial resolution at large scales.
Aiming at the integration of the nanocomposite scaffolds into
3D cell environments, we characterized the rheological behavior
of the hydrogels to be used as inks for 3D printing, followed by
the biocompatibility and mechanical stability of the scaffolds for
extended periods of time (more than 1 week in vitro). The
results (Figure S5) demonstrate a shear-thinning behavior of the
inks within the usual shear rate range for 3D printing, thus
enhancing their printability. By use of these inks, grid-like
scaffolds with holes of around 700 μm were obtained, according
to scanning electron microscopy (SEM) images (Figure S5g).
Regarding the stability of the printed scaffolds, maximum
swelling was recorded after 7 days of incubation in complete
media (cDMEM) and hydrolytic degradation was noticeable
after 14 days of incubation (Figure S5f). MCF-7 cancer cells,
which exhibit features of mammary epithelium, were selected as
the biological model owing to their well-described behavior in
3D cell cultures and their sensitivity to MB therapy.29,42 Using a
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tailored cell culture device was essential toward successfully
implementing a homogeneous cell distribution within 3D-
printed plasmonic scaffolds. The system (Figure 2a) comprised
a central chamber where the supporting scaffolds could be fixed
while using a commercial extracellular matrix (Matrigel) to
uniformly sustain the cells (Figure 2b). A lateral reservoir was
incorporated into the device (Figure 2a, inset) to challenge the
3D cell environment with reproducible MB gradients. Mean-
while, the media well, located above the scaffold/hydrogel
chamber, provides the necessary nutrients to the 3D culture and
supports the use of dip-in immersion objectives during SERS
measurements (dimensions indicated in Figure S6). Following
this approach, MCF-7 cells were efficiently seeded in the device
and remained viable for several days, forming tumor-like cell
aggregates after 3−4 days in vitro, throughout the entire 3D
extracellular matrix (see confocal microscopy images in Figures
2c and S7).
As a first example of application, we monitored drug delivery
using poly lactic-co-glycolic acid (PLGA) capsules containing
MB. On account of the well-known spontaneous PLGA
degradation in cell environments,43,44 encapsulated MB was
gradually released into the medium, where it could be detected
by SERS. As shown in Figure S8, we first confirmed that drug
monitoring could be performed over time, within 3D-printed
nanocomposite scaffolds. Subsequently, we assessed the
potential of the system to visualize MB diffusion. In these
experiments, scaffolds were placed within our homemade
devices, followed by addition of MB from the lateral reservoir
(Figure 2a). As illustrated in Figure 3a, the localized drug
delivery created a MB gradient that could be imaged by SERS.
We initially selected two neighboring areas in the plasmonic
scaffold, separated by 1 mm from each other, to register SERS
intensity upon MB administration (10 μM). The area located
closer to the compound reservoir (labeled as 1) showed a rapid
response to MB (fewer than 30 min), whereas the farthest area
(labeled as 2) reached a comparable level with an 1 h delay.
These results, in addition to those presented in Figure S9,
demonstrate a suitable spatiotemporal resolution in SERS
imaging, whichmay account forMB gradients along the scaffold,
in three dimensions. We then analyzed the impact of the ECM,
in this case Matrigel, and of the presence of cells, on MB
diffusion. To this end, we performed a similar experiment
(localized drug delivery from the compound reservoir), but
incorporating Matrigel, either with or without embedded MCF-
7 cells. Upon MB administration, we scanned sufficiently large
areas (8 mm × 3 mm) of the scaffold at different incubation
times (1, 2, and 24 h). The corresponding maps (Figure 3b)
confirm the formation of MB gradients (at different conditions
and times) with meaningful and varying SERS profiles. In
contrast to the control conditions, significantly restricted MB
diffusion occurred in the presence of both Matrigel and MCF-7
cells. We observed (Figure S10) that hindered diffusion strongly
affectedMB distribution at early time points (1 and 2 h) whereas
a similar equilibrium situation was reached for all experimental
conditions within 24 h. Similar effects are shown in Figure 3c, in
which the administration of MB was performed from the top of
Figure 2. (a) Scheme of a custom-made device to integrate nanocomposite scaffolds within a 3D tumor cell environment, comprisingMCF-7 cells and
Matrigel. The presence of a lateral reservoir (see inset) allows for controlledMB delivery. (b) 3D reconstruction of confocal images of growingMCF-7
cells embedded inMatrigel within the supporting scaffold. DimensionsXYZ = 2700 μm× 2700 μm× 300 μm. (c)Highermagnification image showing
cancer cell clusters formed under these conditions. Dimensions XYZ = 900 μm × 900 μm × 300 μm.
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the scaffold chamber so as to establish a gradient along the Z-
axis. Using the confocal microscopy mode, we observed that the
presence of MCF-7 not only hindered MB diffusion but also
originated a more heterogeneous distribution along the XZ-
plane (control condition shown in Figure S11). Besides, the
total SERS intensity at 24 h was consistently lower in
experiments with cells (Figure S10b,c). To clarify these results,
we investigated whether MCF-7 cells were effectively taking up
Figure 3. (a) Schematic view of the experimental setup to monitor MB diffusion by SERS. Two neighboring areas of the plasmonic scaffold, separated
from each other by 1mm in X, were selected to register the SERS intensity at successive times uponMB administration.Maps were recorded with a 785
nm laser through a 20× objective with laser power of 15 mW, 10 ms integration time, and a step size of 16 μm. Scale bars: 200 μm. (b) MB diffusion
patterns along theX-axis in pristine nanocomposite scaffolds, scaffolds embedded inMatrigel, andMatrigel loaded with high cell density (2× 106 cells/
mL). The SERS signal (at 450 cm−1) was acquired at indicated times (1, 2, and 24 h) after MB delivery from the lateral reservoir. An excitation laser at
785 nm through a 10× objective, with a power of 15.15 mW for 0.1 s, was used for all measurements. Scale bars: 600 μm. (c) SERS profile maps (XZ
plane) of the nanocomposite scaffold within Matrigel and cell-containing Matrigel, after MB administration from the top media well. Confocal SERS
mappings were recorded with a 785 nm excitation laser through a 20×water immersion objective, 7 mW power, 50 ms integration time, and a step size
of 10 μm. Scale bars: 200 μm. (d) Flow cytometry analysis of the uptake of MB by cells retrieved from the 3D culture. The fluorescence from MB
increased in a dose-dependent manner. The gating indicates positive and negative cell populations after applying the PerCP-Cy5.5 emission filter
(670/40).
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MB from the extracellular milieu, thereby affecting its diffusion.
In this context, MB could also serve as a fluorophore probe with
emission around 690 nm so that cells uptaking MB would
display higher emission intensities at this wavelength. We
interrogated MCF-7 cells upon Matrigel depolymerization and
subsequent cell retrieval, via flow cytometry (Figure 3d), which
confirmed intracellular accumulation of MB in a dose-depend-
ent manner. We thus interpret the creation of different diffusion
profiles as the result of three main factors: drug diffusivity,
extracellular matrix permeability, and intracellular accumulation
of MB.45,46
We finally sought to monitor the SERS signal at different MB
concentrations over time, correlating with the cell viability
resulting from treatments with the selected MB doses. It should
be noted that the use of MB as a drug against tumors requires a
drug activation step by illumination at an appropriate wave-
length (≈640 nm).47 Upon exposure to light, the photo-
sensitizer (MB molecules) would start generating reactive
oxygen species (ROS), eventually inducing cell death. In the
experiments discussed so far, MB was applied without light
activation (dark conditions) so that no significant cytotoxic
activity was observed (Figure S12). In this case, we monitored
both the distribution of MB and its cytotoxicity by challenging
3D cell cultures with increasing doses of photoactivated MB
solution (control, 1 μM, and 20 μM). This means that free MB
was illuminated by a red light lamp prior to administration from
the lateral reservoir of the cell culture device. Subsequently, drug
diffusion was imaged through the SERS fingerprint of MB at two
different time points (2 and 24 h), followed by evaluation of cell
viability at the end of the experiment (24 h). The patterns of MB
distribution through the scaffold at selected times are plotted in
Figure 4a. As expected, the amount of MB was found to dictate
both the recorded SERS intensities and the number of dying
cells. For example, whereas at 1 μM MB no SERS signal was
Figure 4. (a) SERS intensity at increasing doses of MB (control, 1 μM, and 20 μM), registered by scaffolds at different points from the reservoir after 2
h (upper panel) and 24 h (lower panel). Gray lines represent the standard deviation from six spectra (N = 2 samples, n = 3 spectra). An excitation laser
at 785 nm through a 10× objective, with a power of 15.15 mW for 1 s, was used for all measurements. (b) Luminescence output 24 h after MB
administration monitored with CellTiter-Glo 3D cell viability assay. Error bars indicate the standard derivation of multiple wells measured from the
same experiment. (c) Flow cytometry analysis representing quantified single cells labeled with propodium iodide (PI) after treatment with 1 μM and
20 μM MB. The gating indicates the positive and negative cell population after applying a PE emission filter (585/42). (d) Maximum intensity
projection (XY) images of a representative live confocal image. 3D cells growing in Matrigel and within the nanocomposite scaffold were labeled with
PI for visualizing cytotoxic effects 24 h after dispensing 1 μM MB. Images correspond to a 400 μm thick Z-stack. Scale bar: 500 μm. (e) Two-
dimensional representation of the Z-stack projection of 3D live confocal images. Analysis was performed after a 2 h MB treatment to visualize the
cytotoxicity gradient. Lines indicate columns into which the images were divided to study the distribution of PI (red) and GFP signals (green). (f)
Automated quantification of cell death percentage for control and 20 μMsamples, segmented by columns. Dotted line indicates the profile of cell death
with the distance.
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detected at areas far away (more than 5 mm) from the lateral
reservoir during the first 2 h, a high SERS intensity could be
readily registered when 20 μM MB was used. Quantification of
cell viability by CellTiter-Glo test (Figure 4b) and flow
cytometry (Figure 4c) after recovery of cellular aggregates
from Matrigel demonstrated the dose-dependent cytotoxic
effect of MB on the entire cell population and for single-cell
measurements. Likewise, live confocal imaging (Figure 4d) was
conducted by following dead cells labeled with propidium iodide
(PI). Images of the entire culture volume around the scaffold
were captured to examine the spatiotemporal distribution of
affected cells and to correlate drug gradients with the spatial
distribution of dead cells in 3D.
Imaging of cytotoxicity gradients was attempted 24 h after the
addition of photoactivated MB. However, homogeneous cell
death across the 3D culture was observed at this time by confocal
microscopy imaging (Figure S13). This result is in agreement
with SERS results for drug distribution over 24 h (Figures 3b and
4a), which show uniform drug distribution throughout the
scaffold. Therefore, we developed an alternative approach to
enhance the cell death gradient, based on our previous MB
transport studies. The new strategy consisted of replacing cell
media at 2 h after MB administration from the lateral reservoir,
thereby rinsing extracellular MB from the 3D culture. By
subsequent irradiation with the red lamp, we photoactivated
primarily MB that had been uptaken by cells, as well as any
remaining MB present in the area closest to the reservoir.
Automated quantification of fluorescence images after 24 h
(Figure 4e) revealed a well-defined gradient of dying cells along
the X-axis (Figure 4f), in contrast to results obtained under
control conditions or without extracellular drug removal (see
Figure S14 for statistical analysis).
■ CONCLUSIONS
In summary, the present study provides compelling evidence
supporting the use of plasmonic scaffolds as suitable SERS
platforms for drug transport monitoring. By integrating 3D-
printed composite scaffolds within a customized cell culture
device, we could achieve a closer recreation of different
compound gradients. The same system allowed us to monitor
the impact of drug diffusion and to better understand its
cytotoxic effect on a 3D cell culture model. The selection of MB
as a proof-of-concept drug candidate allowed us to demonstrate
that label-free SERS studies can be performed in 3D, under
various conditions, whichmay enable the calculation of diffusion
coefficients in future studies. The real-time images obtained
regarding these processes evidenced the value of this system to
study the extracellular environment in vitro, thereby deciphering
the biochemical and biophysical factors involved in drug
transport, which might harbor therapeutic relevance.
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K. G.; Tian, Z. Q.; Van Duyne, R. P.; Vo-Dinh, T.; Wang, Y.; Willets, K.
A.; Xu, C.; Xu, H.; Xu, Y.; Yamamoto, Y. S.; Zhao, B.; Liz-Marzán, L. M.
Present and Future of Surface-Enhanced Raman Scattering. ACS Nano
2020, 14, 28−117.
(25) Plou, J.; García, I.; Charconnet, M.; Astobiza, I.; García-Astrain,
C.; Matricardi, C.; Mihi, A.; Carracedo, A.; Liz-Marzán, L. M.Multiplex
SERS Detection of Metabolic Alterations in Tumor Extracellular
Media. Adv. Funct. Mater. 2020, 30, 1910335.
(26) Bodelón, G.; Montes-García, V.; Costas, C.; Pérez-Juste, I.;
Pérez-Juste, J.; Pastoriza-Santos, I.; Liz-Marzán, L. M. Imaging Bacterial
Interspecies Chemical Interactions by Surface-Enhanced Raman
Scattering. ACS Nano 2017, 11, 4631−4640.
(27) García-Astrain, C.; Lenzi, E.; Jimenez de Aberasturi, D.;
Henriksen-Lacey, M.; Binelli, M. R.; Liz-Marzán, L. M. 3D-Printed
Biocompatible Scaffolds with Built-In Nanoplasmonic Sensors. Adv.
Funct. Mater. 2020, 30, 2005407.
(28) Srichan, C.; Ekpanyapong, M.; Horprathum, M.; Eiamchai, P.;
Nuntawong, N.; Phokharatkul, D.; Danvirutai, P.; Bohez, E.;
Wisitsoraat, A.; Tuantranont, A. Highly-Sensitive Surface-Enhanced
Raman Spectroscopy (SERS)-Based Chemical Sensor Using 3D
Graphene Foam Decorated with Silver Nanoparticles as SERS
Substrate. Sci. Rep. 2016, 6, 23733.
(29) dos Santos, A. F.; Terra, L. F.; Wailemann, R. A. M.; Oliveira, T.
C.; de Morais Gomes, V.; Mineiro, M. F.; Meotti, F. C.; Bruni-Cardoso,
A.; Baptista, M. S.; Labriola, L. Methylene Blue Photodynamic Therapy
Induces Selective and Massive Cell Death in Human Breast Cancer
Cells. BMC Cancer 2017, 17, 194.
(30) Wu, P. T.; Lin, C. L.; Lin, C. W.; Chang, N. C.; Tsai, W. B.; Yu, J.
Methylene-Blue-Encapsulated Liposomes as Photodynamic Therapy
Nano Agents for Breast Cancer Cells. Nanomaterials 2019, 9, 14.
(31) Pastoriza-Santos, I.; Kinnear, C.; Pérez-Juste, J.; Mulvaney, P.;
Liz-Marzán, L. M. Plasmonic Polymer Nanocomposites. Nat. Rev.
Mater. 2018, 3, 375−391.
(32) Zhu, K.; Shin, S. R.; van Kempen, T.; Li, Y. C.; Ponraj, V.;
Nasajpour, A.; Mandla, S.; Hu, N.; Liu, X.; Leijten, J.; Lin, Y. D.;
Hussain, M. A.; Zhang, Y. S.; Tamayol, A.; Khademhosseini, A. Gold
Nano Letters pubs.acs.org/NanoLett Letter
https://doi.org/10.1021/acs.nanolett.1c03070
Nano Lett. 2021, 21, 8785−8793
8792
Nanocomposite Bioink for Printing 3D Cardiac Constructs. Adv. Funct.
Mater. 2017, 27, 1605352.
(33) Erben, A.; Hörning, M.; Hartmann, B.; Becke, T.; Eisler, S. A.;
Southan, A.; Cranz, S.; Hayden, O.; Kneidinger, N.; Königshoff, M.;
Lindner, M.; Tovar, G. E. M.; Burgstaller, G.; Clausen-Schaumann, H.;
Sudhop, S.; Heymann, M. Precision 3D-Printed Cell Scaffolds
Mimicking Native Tissue Composition andMechanics. Adv. Healthcare
Mater. 2020, 9, 2000918.
(34) Tibbitt, M. W.; Anseth, K. S. Hydrogels as Extracellular Matrix
Mimics for 3D Cell Culture. Biotechnol. Bioeng. 2009, 103, 655−663.
(35) Afewerki, S.; Sheikhi, A.; Kannan, S.; Ahadian, S.;
Khademhosseini, A. Gelatin-Polysaccharide Composite Scaffolds for
3D Cell Culture and Tissue Engineering: Towards Natural
Therapeutics. Bioeng. Transl. Med. 2019, 4, 96−115.
(36) Kundu, S.; Nithiyanantham, U. In situ Formation of Curcumin
Stabilized Shape-selective Ag Nanostructures in Aqueous Solution and
their Pronounced SERS aActivity. RSC Adv. 2013, 3, 25278.
(37) Shin, Y.; Jeon, I.; You, Y.; Song, G.; Lee, T. K.; Oh, J.; Son, C.;
Baek, D.; Kim, D.; Cho, H.; Hwang, H.; Kim, T.; Kwak, S. K.; Kim, J.;
Lee, J. Facile Microfluidic Fabrication of 3D Hydrogel SERS Substrate
with High Reusability and Reproducibility via Programmable Maskless
Flow Microlithography. Adv. Opt. Mater. 2020, 8, 2001586.
(38) Kim, D. J.; Park, S. G.; Kim, D. H.; Kim, S. H. SERS-Active-
Charged Microgels for Size- and Charge-Selective Molecular Analysis
of Complex Biological Samples. Small 2018, 14, 1802520.
(39) Lieleg, O.; Ribbeck, K. Biological hydrogels as selective diffusion
barriers. Trends Cell Biol. 2011, 21, 543−551.
(40) Dumont, E.; De Bleye, C.; Rademaker, G.; Coïc, L.; Horne, J.;
Sacré, P. Y.; Peulen, O.; Hubert, P.; Ziemons, E. Development of a
Prototype Device for near Real-Time Surface-Enhanced Raman
Scattering Monitoring of Biological Samples. Talanta 2021, 224,
121866.
(41) Orth, K.; Beck, G.; Genze, F.; Rück, A. Methylene BlueMediated
Photodynamic Therapy in Experimental Colorectal Tumors in Mice. J.
Photochem. Photobiol., B 2000, 57, 186−192.
(42) Vantangoli, M. M.; Madnick, S. J.; Huse, S. M.; Weston, P.;
Boekelheide, K. MCF-7 Human Breast Cancer Cells Form Differ-
entiated Microtissues in Scaffold-Free Hydrogels. PLoS One 2015, 10,
e0135426.
(43) Shen, X.; Li, T.; Xie, X.; Feng, Y.; Chen, Z.; Yang, H.; Wu, C.;
Deng, S.; Liu, Y. PLGA-Based Drug Delivery Systems for Remotely
Triggered Cancer Therapeutic and Diagnostic Applications. Front.
Bioeng. Biotechnol. 2020, 8, 381.
(44) Ghitman, J.; Biru, E. I.; Stan, R.; Iovu, H. Review ofHybrid PLGA
Nanoparticles: Future of Smart Drug Delivery and Theranostics
Medicine. Mater. Des. 2020, 193, 108805.
(45) Dewhirst, M. W.; Secomb, T. W. Transport of Drugs from Blood
Vessels to Tumour Tissue. Nat. Rev. Cancer 2017, 17, 738−750.
(46) Han, B.; Qu, C.; Park, K.; Konieczny, S. F.; Korc, M.
Recapitulation of Complex Transport and Action of Drugs at the
Tumor Microenvironment Using Tumor-Microenvironment-on-Chip.
Cancer Lett. 2016, 380, 319−329.
(47) Klosowski, E. M.; de Souza, B. T. L.; Mito, M. S.; Constantin, R.
P.; Mantovanelli, G. C.; Mewes, J. M.; Bizerra, P. F. V.; da Costa
Menezes, P. V. M.; Gilglioni, E. H.; Utsunomiya, K. S.; Marchiosi, R.;
dos Santos, W. D.; Filho, O. F.; Caetano, W.; de Souza Pereira, P. C.;
Goncalves, R. S.; Constantin, J.; Ishii-Iwamoto, E. L.; Constantin, R. P.
The Photodynamic and Direct Actions of Methylene Blue on
Mitochondrial Energy Metabolism: A Balance of the Useful and
Harmful Effects of This Photosensitizer. Free Radical Biol. Med. 2020,
153, 34−53.
Nano Letters pubs.acs.org/NanoLett Letter
https://doi.org/10.1021/acs.nanolett.1c03070
Nano Lett. 2021, 21, 8785−8793
8793
